维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="Chansky S"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small cell lung cancer:Phase II Southwest Oncology Group Study S9504显示文摘	David R Gandara Kari Chansky Kathy S	2003	J Clin Oncol2003，21，10：	1
2	Serum lactate as a predictor of mortality in patients with infection显示文摘	Trzeciak S Dellinger RP Chansky ME	2007	Intensive Care Med2007，33，6：	1
3	Serum lactate as a pre- dictor of mortality in patients with infection显示文摘	Trzeciak S Dellinger RP Chansky ME	2007	Intensive Care Med2007，33，6：	1
4	Time from treatment to subsequent diagnosis of brain metastases in stage Ⅲ non-small-cell cancer:A retrospective review by the Southwest Oncology Group显示文摘	Gaspa L E Chansky K Albain K S	2005	J Clin Oncol2005，23，1：	1
5	Gemcitabin and cisplatin for patients with metastatic or recurrent esophageal carcinoma : a Southwest Oncology Group Study 显示文摘	Urba SG Chansky S Vanveldhuizen PJ	2004	Invest New Drugs2004，2，1：	1
6	Serum lactate as a predictor of mortality in patients with in- fection显示文摘	Trzeciak S Dellinger RP Chansky ME	2007	Intensive Care Med2007，33，6：	1
7	Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma:a Southwest Oncology Group Study显示文摘	Urba S G Chansky K VanVeldhuizen P J	2004	Invest New Drugs2004，22，1：	1
8	Long term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage Ⅲ B non-small-cell lung cancer: a phase Ⅱ Southwest Oncology Group Study (S9504)显示文摘	Gandara D R Chansky K Albain K S	2006	Clin Lung Cancer2006，8，2：	1
9	Serum lactate as a predictor of mortality in patients with infection显示文摘	Trzeciak S Dellinger R P Chansky M E Arnold R C Schorr C Milcarek B	2007	Intensive Care Med2007，33，：	1
10	Serumlactate as a predictor of mortality in patients w ith infec-tion显示文摘	Trzeciak S Dellinger R P Chansky M E	2007	Intensive Care Med2007，33，6：	1
11	Gemcitabine and cisplatin for patients with metastistatic or recurrent esophageal carcinoma,Invest显示文摘	Urba S G Chansky K VanVeldhuizen P J	2004	New Drugs2004，22，1：	1
12	Serumlactate as a predictor of mortality in patients with infeetion显示文摘	Trzeciak S Dellinger RP Chansky ME	2007	In- tensive Care Med2007，33，6：	1
13	Serum lactate asa predictor of mortality in patients with infection显示文摘	Trzeciak S Dellinger RP Chansky ME	2007	IntensiveCare Med2007，33，6：	1
14	Serum lactate as a predictor of mortality in patients with infection显示文摘	TRZECIAK S DELLINGER R P CHANSKY M E	2007	Intensive Care Med2007，33，：	1
15	Serum lactate as a pre- dictor of mortality in patients with infection 显示文摘	Trzeciak S Dellingcr RP Chansky ME	2007	Intensive Care Meal2007，33，6：	1
16	Serum lactate as a predictor of mortality in patients with infection显示文摘	Trzeciak S Dellinger RP Chansky ME		0，，06：	1
17	Serum lactate as a predic- tor of mortality in patients with infection 显示文摘	Trzeciak S Dellinger RP Chansky ME	2007	Intensive Care Med2007，33，6：	1
18	Time from treatment to subsequent diagnosis of brain metastases in stage Ⅲ non-small cell lung cancer: a retrospective review by southwest oncology group显示文摘	GASPAR L E CHANSKY K ALBAIN K S	2005	J Clin Oncol2005，23，：	1
19	Gemcitabine and cisplatin for patients with metastatic or recurrent esophagcal carcinoma:A Southwest Oncology Group Study显示文摘	Urba S G Chansky K Van Veldhuizen P J	2004	Invest New Drugs2004，22，1：	1
20	Serumlactate as a predictor of mortality in patients withinfection显示文摘	Trzeciak S Dellinger RP Chansky ME	2007	Intensive Care Med2007，33，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示